Skip to main content
. 2007 Jan 11;66(8):1033–1037. doi: 10.1136/ard.2006.062463

Table 2 Ex vivo interleukin 1β and interleukin 1 receptor antagonist production*.

Cytokine Patients with RA (n = 76) Controls (n = 63) p Value
IL1β 1536 (606–2854) † 2773 (1487–4901) <0.001
IL1Ra 29 010 (20 459–41 195) 18 234 (14 387–22 293) <0.001

IL1β, interleukin 1 beta; IL1Ra, interleukin 1 receptor antagonist; RA, rheumatoid arthritis.

Of patients with recent‐onset RA and healthy controls, on stimulation with lipopolysaccharide; pg/ml; median (interquartile range).

†n = 75 patients.